The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Menopause Drugs Market Research Report 2024
Synopsis
Menopause is the end of a woman’s menstrual cycles. The term can describe any of the changes you go through just before or after you stop having your period, marking the end of your reproductive years.
The global Menopause Drugs market was valued at US$ 9860.3 million in 2023 and is anticipated to reach US$ 11850 million by 2030, witnessing a CAGR of 2.6% during the forecast period 2024-2030.
The menopause drugs market is primarily driven by the increasing aging population of women and the growing awareness of menopausal symptoms and their management. As women approach menopause, they often experience symptoms like hot flashes, mood swings, and sleep disturbances, leading to a rising demand for effective treatments. Hormone replacement therapy (HRT) and non-hormonal drugs are commonly prescribed to alleviate these symptoms, contributing to market growth. However, challenges in this market include concerns related to the long-term use of hormone therapy, potential side effects, and the need for personalized treatment plans. There is ongoing research to develop safer and more tailored therapies for menopausal symptom management. Additionally, cultural and societal factors can influence the acceptance and utilization of menopause drugs, making it important for pharmaceutical companies to address these aspects to succeed in the market.
This report aims to provide a comprehensive presentation of the global market for Menopause Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Menopause Drugs.
Report Scope
The Menopause Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Menopause Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Menopause Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly
Pfizer
AbbVie
Novo Nordisk
Merck KGaA
Viatris
Bayer
Teva
Novartis
Abbott
Roche
Endo International
Ipsen
Segment by Type
Parenteral
Transdermal
Oral
Others
Segment by Application
Hospitals
Drugstores
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Menopause Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Menopause is the end of a woman’s menstrual cycles. The term can describe any of the changes you go through just before or after you stop having your period, marking the end of your reproductive years.
The global Menopause Drugs market was valued at US$ 9860.3 million in 2023 and is anticipated to reach US$ 11850 million by 2030, witnessing a CAGR of 2.6% during the forecast period 2024-2030.
The menopause drugs market is primarily driven by the increasing aging population of women and the growing awareness of menopausal symptoms and their management. As women approach menopause, they often experience symptoms like hot flashes, mood swings, and sleep disturbances, leading to a rising demand for effective treatments. Hormone replacement therapy (HRT) and non-hormonal drugs are commonly prescribed to alleviate these symptoms, contributing to market growth. However, challenges in this market include concerns related to the long-term use of hormone therapy, potential side effects, and the need for personalized treatment plans. There is ongoing research to develop safer and more tailored therapies for menopausal symptom management. Additionally, cultural and societal factors can influence the acceptance and utilization of menopause drugs, making it important for pharmaceutical companies to address these aspects to succeed in the market.
This report aims to provide a comprehensive presentation of the global market for Menopause Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Menopause Drugs.
Report Scope
The Menopause Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Menopause Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Menopause Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly
Pfizer
AbbVie
Novo Nordisk
Merck KGaA
Viatris
Bayer
Teva
Novartis
Abbott
Roche
Endo International
Ipsen
Segment by Type
Parenteral
Transdermal
Oral
Others
Segment by Application
Hospitals
Drugstores
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Menopause Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Menopause Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Parenteral
1.2.3 Transdermal
1.2.4 Oral
1.2.5 Others
1.3 Market by Application
1.3.1 Global Menopause Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Menopause Drugs Market Perspective (2019-2030)
2.2 Menopause Drugs Growth Trends by Region
2.2.1 Global Menopause Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Menopause Drugs Historic Market Size by Region (2019-2024)
2.2.3 Menopause Drugs Forecasted Market Size by Region (2025-2030)
2.3 Menopause Drugs Market Dynamics
2.3.1 Menopause Drugs Industry Trends
2.3.2 Menopause Drugs Market Drivers
2.3.3 Menopause Drugs Market Challenges
2.3.4 Menopause Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Menopause Drugs Players by Revenue
3.1.1 Global Top Menopause Drugs Players by Revenue (2019-2024)
3.1.2 Global Menopause Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Menopause Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Menopause Drugs Revenue
3.4 Global Menopause Drugs Market Concentration Ratio
3.4.1 Global Menopause Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Menopause Drugs Revenue in 2023
3.5 Menopause Drugs Key Players Head office and Area Served
3.6 Key Players Menopause Drugs Product Solution and Service
3.7 Date of Enter into Menopause Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Menopause Drugs Breakdown Data by Type
4.1 Global Menopause Drugs Historic Market Size by Type (2019-2024)
4.2 Global Menopause Drugs Forecasted Market Size by Type (2025-2030)
5 Menopause Drugs Breakdown Data by Application
5.1 Global Menopause Drugs Historic Market Size by Application (2019-2024)
5.2 Global Menopause Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Menopause Drugs Market Size (2019-2030)
6.2 North America Menopause Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Menopause Drugs Market Size by Country (2019-2024)
6.4 North America Menopause Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Menopause Drugs Market Size (2019-2030)
7.2 Europe Menopause Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Menopause Drugs Market Size by Country (2019-2024)
7.4 Europe Menopause Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Menopause Drugs Market Size (2019-2030)
8.2 Asia-Pacific Menopause Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Menopause Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Menopause Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Menopause Drugs Market Size (2019-2030)
9.2 Latin America Menopause Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Menopause Drugs Market Size by Country (2019-2024)
9.4 Latin America Menopause Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Menopause Drugs Market Size (2019-2030)
10.2 Middle East & Africa Menopause Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Menopause Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Menopause Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Detail
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Menopause Drugs Introduction
11.1.4 Eli Lilly Revenue in Menopause Drugs Business (2019-2024)
11.1.5 Eli Lilly Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Menopause Drugs Introduction
11.2.4 Pfizer Revenue in Menopause Drugs Business (2019-2024)
11.2.5 Pfizer Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Detail
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Menopause Drugs Introduction
11.3.4 AbbVie Revenue in Menopause Drugs Business (2019-2024)
11.3.5 AbbVie Recent Development
11.4 Novo Nordisk
11.4.1 Novo Nordisk Company Detail
11.4.2 Novo Nordisk Business Overview
11.4.3 Novo Nordisk Menopause Drugs Introduction
11.4.4 Novo Nordisk Revenue in Menopause Drugs Business (2019-2024)
11.4.5 Novo Nordisk Recent Development
11.5 Merck KGaA
11.5.1 Merck KGaA Company Detail
11.5.2 Merck KGaA Business Overview
11.5.3 Merck KGaA Menopause Drugs Introduction
11.5.4 Merck KGaA Revenue in Menopause Drugs Business (2019-2024)
11.5.5 Merck KGaA Recent Development
11.6 Viatris
11.6.1 Viatris Company Detail
11.6.2 Viatris Business Overview
11.6.3 Viatris Menopause Drugs Introduction
11.6.4 Viatris Revenue in Menopause Drugs Business (2019-2024)
11.6.5 Viatris Recent Development
11.7 Bayer
11.7.1 Bayer Company Detail
11.7.2 Bayer Business Overview
11.7.3 Bayer Menopause Drugs Introduction
11.7.4 Bayer Revenue in Menopause Drugs Business (2019-2024)
11.7.5 Bayer Recent Development
11.8 Teva
11.8.1 Teva Company Detail
11.8.2 Teva Business Overview
11.8.3 Teva Menopause Drugs Introduction
11.8.4 Teva Revenue in Menopause Drugs Business (2019-2024)
11.8.5 Teva Recent Development
11.9 Novartis
11.9.1 Novartis Company Detail
11.9.2 Novartis Business Overview
11.9.3 Novartis Menopause Drugs Introduction
11.9.4 Novartis Revenue in Menopause Drugs Business (2019-2024)
11.9.5 Novartis Recent Development
11.10 Abbott
11.10.1 Abbott Company Detail
11.10.2 Abbott Business Overview
11.10.3 Abbott Menopause Drugs Introduction
11.10.4 Abbott Revenue in Menopause Drugs Business (2019-2024)
11.10.5 Abbott Recent Development
11.11 Roche
11.11.1 Roche Company Detail
11.11.2 Roche Business Overview
11.11.3 Roche Menopause Drugs Introduction
11.11.4 Roche Revenue in Menopause Drugs Business (2019-2024)
11.11.5 Roche Recent Development
11.12 Endo International
11.12.1 Endo International Company Detail
11.12.2 Endo International Business Overview
11.12.3 Endo International Menopause Drugs Introduction
11.12.4 Endo International Revenue in Menopause Drugs Business (2019-2024)
11.12.5 Endo International Recent Development
11.13 Ipsen
11.13.1 Ipsen Company Detail
11.13.2 Ipsen Business Overview
11.13.3 Ipsen Menopause Drugs Introduction
11.13.4 Ipsen Revenue in Menopause Drugs Business (2019-2024)
11.13.5 Ipsen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
